Ocugen, Inc. (OCGN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-04 13:32:13 ET
Ocugen, Inc. (OCGN) Q4 2025 Earnings Call March 4, 2026 8:30 AM EST
Company Participants
Tiffany Hamilton - AVP & Head of Corporate Communications
Shankar Musunuri - Co-Founder, CEO & Chairman
Rita Johnson-Greene - Chief Financial Officer
Huma Qamar - Chief Medical Officer
...
Read the full article on Seeking Alpha
For further details see:
Ocugen, Inc. (OCGN) Q4 2025 Earnings Call Transcript
Ocugen, Inc.
NASDAQ: OCGN
OCGN Trading
-5.03% G/L:
$1.64 Last:
2,843,898 Volume:
$1.74 Open:
OCGN Latest News
March 04, 2026 08:15:00 am
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
OCGN Stock Data
$478,717,026
313,395,708
0.26%
38
N/A
Biotechnology & Life Sciences
Healthcare
US
Malvern
